Longeveron Inc. (LGVN) reported third-quarter 2026 revenue of $115,000 and a net loss of $6.1 million, or $1.91 per basic and diluted share. The company ended September 30 with $7.2 million in cash and cash equivalents.
The clinical-stage biotechnology company said it requested an FDA meeting to review ELPIS II Phase 2b results and potential next steps for its hypoplastic left heart syndrome program. Longeveron is also reviewing strategic and financing alternatives, with Lucid Capital Markets serving as financial advisor.
- Third-quarter total revenue was $115,000, compared with $137,000 a year earlier.
- Net loss was $6.135 million, compared with $7.221 million in the prior-year quarter.
- General and administrative expense was $3.31 million; research and development expense was $3.958 million.
- ELPIS II did not meet its primary efficacy endpoint; the company reported 8 major adverse cardiac events in the standard-of-care arm and 1 in the laromestrocel arm.
- The company expects existing cash to fund operating expenses and capital expenditures into the first quarter of 2027.
$LGVN Hedge Fund Activity
We have seen 16 institutional investors add shares of $LGVN stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOGOS GLOBAL MANAGEMENT LP added 1,287,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $904,761
- MILLENNIUM MANAGEMENT LLC added 907,156 shares (+203.1%) to their portfolio in Q2 2026, for an estimated $637,730
- MARINER, LLC added 126,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $88,578
- HRT FINANCIAL LP removed 118,891 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $83,580
- ADAR1 CAPITAL MANAGEMENT, LLC removed 91,594 shares (-45.8%) from their portfolio in Q2 2026, for an estimated $64,390
- VIRTU FINANCIAL LLC added 58,583 shares (+inf%) to their portfolio in Q2 2026, for an estimated $41,183
- TWO SIGMA SECURITIES, LLC added 55,973 shares (+inf%) to their portfolio in Q2 2026, for an estimated $39,349
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
